Ellie Rapps’ Post

Join Clario on May 16 for an enlightening webinar that explores Parkinson’s disease endpoint data collection. Our experts will delve into topics that include: -Sensitivity of digital measures in disease progression monitoring -Efficacy and quality of life evaluations using clinical scales and patient-reported outcomes -Imaging features for biomarker-guided drug development Register now to gain invaluable insights in Parkinson's disease research: https://lnkd.in/eCN3y5jb #ParkinsonsResearch #EndpointDataCollection #Webinar

#Preclinical researchers in #IPF ( Idiopathic Pulmonary Fibrosis ) >> By reducing the mortality rate from an industry average of 40% to 20%, while maintaining significant and reproducible results, our IPF disease model provides valuable insights to biopharm and biotech companies far more quickly, saving valuable therapeutic discovery and development time and money. Learn more >> https://lnkd.in/gsBchHBF #MLMAdvantage #diseasemodels #preclinicalresearch

Did you know that there are approximately 11,000 rare diseases, and a staggering 95% lack effective treatments? Ever wondered about the challenges and future of rare disease drug development? Join Harsha K Rajasimha Ph.D., Founder & CEO of Jeeva Clinical Trials, on an enlightening journey through rare disease clinical trials, dissecting current research, and exploring clinical trial complexities overcome by rare disease CROs. Don't miss out on this exclusive exploration. Read the blog now!https://lnkd.in/gBQNTU6d #raredisease #rarediseaseresearch #rarediseaseclinicaltrials

There's still time to register for this expert webinar! » https://bit.ly/3wEFJta The world of drug development is evolving with the increased acceptance of real-world evidence (RWE). Disease registries, one of the most clinically rich sources of real-world data (RWD), are at the forefront of this change. These registries are purpose-built for research, allowing the collection of fit-for-purpose data, especially in rare diseases. Register for this expert webinar to gain insights into how RWE and RWD from registries enhance clinical development, approval and post-marketing analyses, particularly for rare diseases.

BIO-Europe really shows the diversity of approaches and indications that our industry is tackling. We met Stéphane Thiroloix, CEO of AlgoTx, at BIO-Europe who explained how the clinical stage II company applies the antidepressant Amitriptyline topically in a highly innovative approach to address chemotherapy-induced neuropathic pain (CINP) and for treatment of the rare disease erythromelalgia. If you couldn’t make it in person, you don’t have to miss out! Subscribe to our YouTube channel to learn more about highlights at the conference here 👉 https://bit.ly/MCS_YouTube #bioeurope #bioeurope2023 #BiotechInvestment #HealthcareInnovation

Last call! Don't miss out on our May 16 webinar exploring Parkinson’s disease endpoint data collection! Our experts will delve into topics that include: -Sensitivity of digital measures in disease progression monitoring -Efficacy and quality of life evaluations using clinical scales and patient-reported outcomes -Imaging features for biomarker-guided drug development Register now to gain invaluable insights in Parkinson's disease research: https://lnkd.in/dcbRjgVt hashtag#ParkinsonsResearch hashtag#EndpointDataCollection hashtag#Webinar

Last call! Don't miss out on our May 16 webinar exploring Parkinson’s disease endpoint data collection! Our experts will delve into topics that include: -Sensitivity of digital measures in disease progression monitoring -Efficacy and quality of life evaluations using clinical scales and patient-reported outcomes -Imaging features for biomarker-guided drug development Register now to gain invaluable insights in Parkinson's disease research: https://lnkd.in/ejzA2FtR hashtag#ParkinsonsResearch hashtag#EndpointDataCollection hashtag#Webinar

Last call! Don't miss out on our May 16 webinar exploring Parkinson’s disease endpoint data collection! Our experts will delve into topics that include: -Sensitivity of digital measures in disease progression monitoring -Efficacy and quality of life evaluations using clinical scales and patient-reported outcomes -Imaging features for biomarker-guided drug development Register now to gain invaluable insights in Parkinson's disease research: https://lnkd.in/eDbq5pAa hashtag#ParkinsonsResearch hashtag#EndpointDataCollection hashtag#Webinar

Increasing numbers of IPF studies and a limited pipeline of participants mean researchers need novel strategies for drug development. Learn how to navigate the changing landscape of research on this rare disease in this blog from our experts. https://ow.ly/VVtR50SwIri

Exciting Webinar Alert! Join our experienced scientists for an in-depth discussion on the power of translational cardiorenal models, with hypertension driving disease progression, in drug development. https://hubs.ly/Q02862Qm0 #Inotiv #ExpectMore #PreclinicalServices #CardiorenalModels